Literature DB >> 26272408

Staphylococcal manipulation of host immune responses.

Vilasack Thammavongsa1, Hwan Keun Kim2, Dominique Missiakas2, Olaf Schneewind2.   

Abstract

<span class="Species">Staphylococcus aureus, a bacterial commensal of the human nares and skin, is a frequent cause of soft tissue and bloodstream infections. A hallmark of staphylococcal infections is their frequent recurrence, even when treated with antibiotics and surgical intervention, which demonstrates the bacterium's ability to manipulate innate and adaptive immune responses. In this Review, we highlight how S. aureus virulence factors inhibit complement activation, block and destroy phagocytic cells and modify host B cell and T cell responses, and we discuss how these insights might be useful for the development of novel therapies against infections with antibiotic resistant strains such as methicillin-resistant S. aureus.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26272408      PMCID: PMC4625792          DOI: 10.1038/nrmicro3521

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  146 in total

1.  Staphylococcus aureus survival in human blood.

Authors:  Natalia Malachowa; Frank R DeLeo
Journal:  Virulence       Date:  2011-11-01       Impact factor: 5.882

2.  Staphylococcus aureus metalloprotease aureolysin cleaves complement C3 to mediate immune evasion.

Authors:  Alexander J Laarman; Maartje Ruyken; Cheryl L Malone; Jos A G van Strijp; Alexander R Horswill; Suzan H M Rooijakkers
Journal:  J Immunol       Date:  2011-04-18       Impact factor: 5.422

3.  Molecular differentiation of historic phage-type 80/81 and contemporary epidemic Staphylococcus aureus.

Authors:  Frank R DeLeo; Adam D Kennedy; Liang Chen; Juliane Bubeck Wardenburg; Scott D Kobayashi; Barun Mathema; Kevin R Braughton; Adeline R Whitney; Amer E Villaruz; Craig A Martens; Stephen F Porcella; Martin J McGavin; Michael Otto; James M Musser; Barry N Kreiswirth
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-24       Impact factor: 11.205

4.  A randomized study of a monoclonal antibody (pagibaximab) to prevent staphylococcal sepsis.

Authors:  Leonard E Weisman; Helen M Thackray; Robin H Steinhorn; William F Walsh; Herbert A Lassiter; Ramasubbareddy Dhanireddy; Beverly S Brozanski; Kristine G H Palmer; Michael S Trautman; Marilyn Escobedo; H Cody Meissner; Pontthenkandath Sasidharan; Jennifer Fretz; John F Kokai-Kun; William G Kramer; Gerald W Fischer; James J Mond
Journal:  Pediatrics       Date:  2011-07-25       Impact factor: 7.124

5.  Antibody responses in furunculosis patients vaccinated with autologous formalin-killed Staphylococcus aureus.

Authors:  S Holtfreter; J Jursa-Kulesza; H Masiuk; N J Verkaik; C de Vogel; J Kolata; M Nowosiad; L Steil; W van Wamel; A van Belkum; U Völker; S Giedrys-Kalemba; B M Bröker
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-22       Impact factor: 3.267

6.  GPVI and GPIbα mediate staphylococcal superantigen-like protein 5 (SSL5) induced platelet activation and direct toward glycans as potential inhibitors.

Authors:  Houyuan Hu; Paul C J Armstrong; Elie Khalil; Yung-Chih Chen; Andreas Straub; Min Li; Juliana Soosairajah; Christoph E Hagemeyer; Nicole Bassler; Dexing Huang; Ingo Ahrens; Guy Krippner; Elizabeth Gardiner; Karlheinz Peter
Journal:  PLoS One       Date:  2011-04-28       Impact factor: 3.240

7.  Global changes in Staphylococcus aureus gene expression in human blood.

Authors:  Natalia Malachowa; Adeline R Whitney; Scott D Kobayashi; Daniel E Sturdevant; Adam D Kennedy; Kevin R Braughton; Duncan W Shabb; Binh An Diep; Henry F Chambers; Michael Otto; Frank R DeLeo
Journal:  PLoS One       Date:  2011-04-15       Impact factor: 3.240

8.  Preventing Staphylococcus aureus sepsis through the inhibition of its agglutination in blood.

Authors:  Molly McAdow; Hwan Keun Kim; Andrea C Dedent; Antoni P A Hendrickx; Olaf Schneewind; Dominique M Missiakas
Journal:  PLoS Pathog       Date:  2011-10-20       Impact factor: 6.823

9.  A very early-branching Staphylococcus aureus lineage lacking the carotenoid pigment staphyloxanthin.

Authors:  Deborah C Holt; Matthew T G Holden; Steven Y C Tong; Santiago Castillo-Ramirez; Louise Clarke; Michael A Quail; Bart J Currie; Julian Parkhill; Stephen D Bentley; Edward J Feil; Philip M Giffard
Journal:  Genome Biol Evol       Date:  2011-08-02       Impact factor: 3.416

10.  The dynamics of T cells during persistent Staphylococcus aureus infection: from antigen-reactivity to in vivo anergy.

Authors:  Christina Ziegler; Oliver Goldmann; Elias Hobeika; Robert Geffers; Georg Peters; Eva Medina
Journal:  EMBO Mol Med       Date:  2011-09-02       Impact factor: 12.137

View more
  208 in total

1.  A new approach to toxin neutralization in Staphylococcus aureus therapy.

Authors:  Dane Parker; Alice Prince
Journal:  EMBO Rep       Date:  2016-02-08       Impact factor: 8.807

2.  Neutralizing Alpha-Toxin Accelerates Healing of Staphylococcus aureus-Infected Wounds in Nondiabetic and Diabetic Mice.

Authors:  Roger V Ortines; Haiyun Liu; Lily I Cheng; Taylor S Cohen; Heather Lawlor; Abhishek Gami; Yu Wang; Carly A Dillen; Nathan K Archer; Robert J Miller; Alyssa G Ashbaugh; Bret L Pinsker; Mark C Marchitto; Christine Tkaczyk; C Kendall Stover; Bret R Sellman; Lloyd S Miller
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

3.  Staphylococcal Protein Secretion and Envelope Assembly.

Authors:  Olaf Schneewind; Dominique M Missiakas
Journal:  Microbiol Spectr       Date:  2019-07

4.  The Staphylococcus aureus ArlRS two-component system regulates virulence factor expression through MgrA.

Authors:  Heidi A Crosby; Nitija Tiwari; Jakub M Kwiecinski; Zhen Xu; Allison Dykstra; Christian Jenul; Ernesto J Fuentes; Alexander R Horswill
Journal:  Mol Microbiol       Date:  2019-11-06       Impact factor: 3.501

5.  Host Nitric Oxide Disrupts Microbial Cell-to-Cell Communication to Inhibit Staphylococcal Virulence.

Authors:  Rodolfo Urbano; Joyce E Karlinsey; Stephen J Libby; Paschalis-Thomas Doulias; Harry Ischiropoulos; Helen I Warheit-Niemi; Denny H Liggitt; Alexander R Horswill; Ferric C Fang
Journal:  Cell Host Microbe       Date:  2018-05-09       Impact factor: 21.023

6.  The structural basis for inhibition of the classical and lectin complement pathways by S. aureus extracellular adherence protein.

Authors:  Jordan L Woehl; Kasra X Ramyar; Benjamin B Katz; John K Walker; Brian V Geisbrecht
Journal:  Protein Sci       Date:  2017-05-31       Impact factor: 6.725

7.  Soluble membrane attack complex is diagnostic for intraventricular shunt infection in children.

Authors:  Theresa N Ramos; Anastasia A Arynchyna; Tessa E Blackburn; Scott R Barnum; James M Johnston
Journal:  JCI Insight       Date:  2016-07-07

8.  Improved Protection in a Rabbit Model of Community-Associated Methicillin-Resistant Staphylococcus aureus Necrotizing Pneumonia upon Neutralization of Leukocidins in Addition to Alpha-Hemolysin.

Authors:  Binh An Diep; Vien T M Le; Zehra C Visram; Harald Rouha; Lukas Stulik; Etyene Castro Dip; Gábor Nagy; Eszter Nagy
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

Review 9.  Interaction of host and Staphylococcus aureus protease-system regulates virulence and pathogenicity.

Authors:  Vigyasa Singh; Ujjal Jyoti Phukan
Journal:  Med Microbiol Immunol       Date:  2018-11-27       Impact factor: 3.402

Review 10.  Staphylococcus aureus Aggregation and Coagulation Mechanisms, and Their Function in Host-Pathogen Interactions.

Authors:  H A Crosby; J Kwiecinski; A R Horswill
Journal:  Adv Appl Microbiol       Date:  2016-08-04       Impact factor: 5.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.